Former NIH Director on U.S. Authorities Targeting of Chinese Researchers

AdobeStock_193313008 TrialsiteN

Elias Zerhouni has been around the drug development block. A former NIH director as well as head of R&D at Sanofi, Mr. Zerhouni expressed deep concern about the future of biotech in the U.S. and everywhere given growing scrutiny of Chinese-born scientists working in the United States. While ensuring that trade secrets are secure is of paramount importance so too is an open collaboration, communication and knowledge exchange between China and America. Follow the link to the Science opinion editorial for an important read.